Document is current
Any future updates will be listed below
-
Authors
Lassen, Espen Rasmussen https://orcid.org/0000-0001-6655-4178
Birkeland, Marianne Skogbrott https://orcid.org/0000-0002-2388-8474
Egeland, Karina https://orcid.org/0000-0002-6757-4696
Stene, Lise Eilin https://orcid.org/0000-0003-3950-8293
Brodersen, Dorte https://orcid.org/0009-0009-6238-033X
Ekornås, Belinda
Reinholdt, Nils Petter https://orcid.org/0000-0002-3090-572X
Kjerstad, Egil https://orcid.org/0000-0002-7395-6535
Lamu, Admassu N. https://orcid.org/0000-0001-6638-421X
Aarons, Gregory A. https://orcid.org/0000-0001-8969-5002
Crable, Erika L. https://orcid.org/0000-0002-2605-5339
Bragesjö, Maria https://orcid.org/0000-0003-2246-3842
Bækkelund, Harald https://orcid.org/0000-0001-9510-7713
-
Funding
Funding for this research was provided by:
Norges Forskningsråd (344341)
- License Information
-
More Information
Article History
Received: 5 November 2025
Accepted: 26 January 2026
First Online: 5 February 2026
Declarations
:
: The trial is approved by the Regional Committee for Medical and Health Research Ethics (REK-sør-øst, #708906) on 23.05.24, and is conducted following guidelines of good clinical practice (GCP) in accordance with the principle of the Declaration of Helsinki. All participants provide written informed consent before enrollment.
: Upon providing informed consent, all participants are informed that the study results will be published in international scientific journals and that identification of individual participants will not be possible based on the manuscripts. A model consent form is available from the PI upon reasonable request.
: MB is the developer of CIPE, but has no financial conflict of interest. The authors declare that they have no competing interests.
